Skip to Content Skip to Content

Immunology

Public not highly knowledgeable about measles risks or MMR vaccine safety

Public not highly knowledgeable about measles risks or MMR vaccine safety

A recent health survey by the Annenberg Public Policy Center finds that the public is less informed than it should be of measles-related risks and less certain than it used to be of the value of vaccination.

From the Annenberg Public Policy Center

2 min. read

What evolutionary and comparative immunology can teach about fish and human immune systems
Oriol Sunyer in his lab.

Penn Vet’s Oriol Sunyer points out rainbow trout, a fish species used in his research.

(Image: Courtesy of Penn Vet)

What evolutionary and comparative immunology can teach about fish and human immune systems

Penn Vet’s J. Oriol Sunyer explores how studying the evolution of the immune system reveals surprising connections between fish and human immunity, and what these discoveries could mean for the development of new therapies for both fish and humans.

Martin Hackett

2 min. read

A cold triggered an autoimmune disease in a Pa. man. Now he’s channeling his challenges into advocacy for people with rare diseases

A cold triggered an autoimmune disease in a Pa. man. Now he’s channeling his challenges into advocacy for people with rare diseases

Research led by Jonathan Sussman of the Perelman School of Medicine found that many rare disease patients report high annual spending on medical costs, reduced work and school hours, and difficulty accessing medication or services after diagnosis.

Dogs with cancer are helping save lives—both canine and human
Nicola Mason, Antonia Rotolo, and Mary Beth Boland with Rex, first dog treated on metastatic osteosarcoma trial.

(Left to right) Nicola Mason, Mary Beth Boland, and Antonia Rotolo with Rex, first dog treated on metastatic osteosarcoma trial.

nocred

Dogs with cancer are helping save lives—both canine and human

The Comparative Immunotherapy Program led by Penn Vet’s Nicola Mason is redefining how therapies are developed and tested—uniting human and veterinary medicine to move promising immunotherapies forward.

4 min. read

Reimagined Penn Medicine facility set to usher in a bold new era of Immune Health discovery
Penn President J. Larry Jameson, Kevin Mahoney and two others cutting a Penn Medicine ribbon at a Ribbon Cutting ceremony.

(From left) Kevin B. Mahoney, chief executive officer of the University of Pennsylvania Health System; Penn President J. Larry Jameson; Jonathan A. Epstein, dean of the Perelman School of Medicine (PSOM); and E. Michael Ostap, senior vice dean and chief scientific officer at PSOM, at the ribbon cutting at 3600 Civic Center Boulevard.

nocred

Reimagined Penn Medicine facility set to usher in a bold new era of Immune Health discovery

3600 Civic Center Boulevard will bring together key researchers and technologies in Immune Health, the Colton Center for Autoimmunity, and infectious diseases to drive breakthrough science.

Eric Horvath

2 min. read

2026 Elaine Redding Brinster Prize honors breakthrough in immune system research

2026 Elaine Redding Brinster Prize honors breakthrough in immune system research

The Institute for Regenerative Medicine at Penn has awarded the Elaine Redding Brinster Prize in Science or Medicine to Zhijian ‘James’ Chen, a biochemist at UT Southwestern Medical Center in Dallas, for his discovery of the DNA-sensing enzyme cyclic GMP-AMP synthase (cGas) and its role in immune and inflammatory response.